UBS Group’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-17
Closed -$4K 7907
2019
Q4
$4K Sell
17
-2,375
-99% -$885K ﹤0.01% 7643
2019
Q3
$1.26M Buy
+2,392
New +$1.77M ﹤0.01% 3754

Other funds holding ACB

UBS Group's ACB Position: Q1 2026 in Review

UBS Group increased its Aurora Cannabis (ACB) stake by 65% in Q1 2026, buying an estimated $227K and bringing the position to 152,268 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #6087.

UBS Group first reported a position in ACB in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.13M in Q2 2021. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • UBS Group held 152,268 shares of Aurora Cannabis worth $498K as of Q1 2026.
  • UBS Group bought 60,198 Aurora Cannabis shares in Q1 2026, an estimated $227K.
  • Aurora Cannabis made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6087 holding.
  • UBS Group first reported a position in Aurora Cannabis in Q4 2018 and has held it in 30 quarters since.
  • UBS Group's Aurora Cannabis position peaked at $2.13M in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.